Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Proteasome Inhibitors
>>
Phase 2
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
oprozomib
(ONX 0912) / Amgen
zetomipzomib
(KZR-616) / Kezar
NNC0385-0434
/ Novo Nordisk
AZD8233
/ AstraZeneca
AZD0780
/ AstraZeneca
frovocimab
(LY3015014) / Eli Lilly
LGT209
/ Novartis
delanzomib
(CEP-18770) / Teva
CIVI 007
/ CiVi Biopharma
LXE408
/ Novartis
RG7652
/ Roche
CVI-LM001
/ CVI Pharma
O304
/ Betagenon
VLX1570
/ Vivolux
